CSL (ASX:CSL) Gains Approval for Updated COVID-19 Vaccine in Japan, Boosting Strategic Alliances
CSL (ASX:CSL) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 25% increase in net profit after tax and innovative product launches, juxtapo...